Found "Digital Medicine": 202 results
Sort by
Last updated

Navigating the Landscape of Digital Health: Australia

Executive Summary Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De

Navigating the Landscape of Digital Health: South Korea

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan

Research Proposal: Convergence of Digital Health Platforms and Health Information Systems (HIS) Implementation in Thailand (ConvergeDH)

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack

Off-label medicines: Rational or Irrational?

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

Unpacking Digital Health: A breakdown of concepts and definitions

Digital health is an umbrella term that includes all healthcare services that are provided by ICT. From one’s personal wearable devices to the use of big data and AI in healthcare come under digital health’ Under the umbrella of digital health technology, various sub-groups such as electronic

English Policy Brief Collection – Volume 1

The English Policy Brief Collection (Volume 1) presents a selection of policy briefs published by the HITAP Foundation. These policy briefs have been categorized under the following key topics: Chapter 1: Designing Universal Health Coverage (UHC) and Healthcare Systems Chapter 2: Managing Rare

Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?

Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los

eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India

– eSanjeevani was developed primarily to tackle the challenges of inequitable healthcare access and the shortage of healthcare professionals in India  – The ‘one application’ approach ensured that only one application is used for the national telemedicine service delivery, thus ensuring interoper

Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access

MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations. The a

Radiation Concerns Rise With Patients’ Exposure

Even in health care systems in which doctors do not bill for each test they administer, the use of diagnostic imaging like CT and PET scans has soared, as has patients’ radiation exposure, a new study has found.The study, published online on Tuesday in The Journal of the American Medical Association
10 / Page